A study of more than 100 patients found that immunotherapy can cure a rare type of cancer in various tumor sites without ...

The results from an ambitious cancer study are giving hope that immunotherapy drugs alone can treat some gastrointestinal tumors, eliminating the need for severe, life-altering surgeries and other ...

According to the results of a new study in the New England Journal of Medicine, 92% of patients who took this drug were cancer-free after two years.

Austin, April 23, 2025 (GLOBE NEWSWIRE) -- Immunotherapy Drugs Market Size & Growth Analysis: According to SNS Insider, The Immunotherapy Drugs Market was estimated at USD 246.00 billion in 2023 ...

While chemotherapy, radiation and surgeries are common for most cancer treatments, immunotherapy is continuing to allow some ...

A new study in the New England Journal of Medicine suggests that some people with early stage cancers may be able to skip surgery after being treated with the immunotherapy drug dostarlimab.

A new clinical trial shows the immunotherapy drug dostarlimab could eliminate the need for surgery and chemotherapy in certain cancers. The results are a medical breakthrough since the drug could ...